A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants

NCT07413367 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmakokinetic
Open Label
Phase 1

Interventions

DRUG: TNX-102 SL Tablet

Sponsor

Tonix Pharmaceuticals, Inc.

Collaborators

[object Object]